Physician profile
Jamie Ghitelman
NPI 1811155518
$33,763.85
in general payments reported to CMS, 2019-2025
42 companies · $4,391 in 2025
The $4,391 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,250 · 2020: $1,522 · 2021: $5,456 · 2022: $6,871 · 2023: $7,343 · 2024: $6,931 · 2025: $4,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $5,100 · Consulting Fee: $900 · Travel and Lodging: $730 · Education: $34.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,900.00 |
| Food and Beverage | $5,099.79 |
| Consulting Fee | $900.00 |
| Travel and Lodging | $730.20 |
| Education | $34.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21,428.67 | 2021-2025 | Venaseal, Micra |
| Abbott Laboratories | $1,447.44 | 2019-2025 | Mitraclip, Ensite, Perclose Proglide |
| Janssen Pharmaceuticals, INC | $1,325.42 | 2019-2024 | Xarelto |
| Cardiva Medical, INC. | $1,101.98 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Zoll Circulation INC | $1,047.60 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Cms Imaging, INC. | $1,016.22 | 2023-2024 | |
| Amgen INC. | $863.53 | 2019-2024 | Repatha |
| Asahi Intecc USA, INC. | $829.42 | 2020-2025 | Peripheral Vascular, Asahi Coronary Wires, Asahi Peripheral Vascular Wires |
| E.R. Squibb & Sons, L.L.C. | $620.52 | 2019-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $614.38 | 2019-2025 | Farxiga, Wainua |
| Novartis Pharmaceuticals Corporation | $473.56 | 2019-2025 | |
| Pfizer INC. | $330.38 | 2019-2025 | |
| Terumo Medical Corporation | $250.00 | 2020 | |
| Impulse Dynamics (USA) INC. | $248.92 | 2021-2025 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $225.77 | 2019-2023 | Lifevest |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $180.21 | 2024 | |
| Medtronic Vascular, INC. | $157.23 | 2020 | |
| Boston Scientific Corporation | $154.07 | 2019-2025 | Watchman Flx, Varithena Administration Pack |
| Astellas Pharma US INC | $129.11 | 2019-2022 | |
| Shockwave Medical, INC | $122.99 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $117.22 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $112.07 | 2019 | |
| Novo Nordisk INC | $111.38 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Kiniksa Pharmaceuticals International, Plc | $99.65 | 2024 | Arcalyst |
| Gilead Sciences, INC. | $95.48 | 2019 | |
| Biotronik INC. | $71.78 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $67.21 | 2021-2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $56.03 | 2024-2025 | Assure Wcd |
| Angiodynamics, INC. | $53.63 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Merck Sharp & Dohme LLC | $45.03 | 2025 | Verquvo |
| Atricure, INC. | $43.67 | 2022-2023 | |
| Lexicon Pharmaceuticals, INC. | $38.86 | 2023 | Inpefa |
| Chiesi USA, INC. | $38.78 | 2022 | |
| Esperion Therapeutics, INC. | $36.06 | 2021-2024 | Nexletol |
| Edwards Lifesciences Corporation | $35.00 | 2023 | |
| Amarin Pharma, INC. | $33.89 | 2019 | |
| Surmodics, INC. | $32.10 | 2025 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Regeneron Healthcare Solutions, INC. | $30.66 | 2019 | |
| Scpharmaceuticals INC. | $25.55 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.65 | 2024 | Jardiance |
| Lilly USA, LLC | $15.54 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $15.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Ghitelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.